To prevent and control 2019 novel coronavirus pneumonia diseases (COVID-19), hundreds of medical teams and tens of thousands of medical professionals throughout the nation were transferred to Hubei to assist COVID-19 control efforts. Medical professionals were at high risk of novel coronavirus pneumonia infections. To ensure the prevention and control of infection in medical teams and prevent cross-infection among medical staff at the medical station, this management standard includes routine management standards, resident disinfection, personnel entry and exit process, and logistics support management, so as to provide reference for medical teams combating COVID-19 in the future.
This article explores the treatment principles of mucormycosis within the framework of international guidelines, systematically reviews the treatment strategies for different clinical types and special populations, as well as the application of surgical and local interventions in different types of mucormycosis, by integrating differences in host status, etiological characteristics, and infection sites of mucormycosis, and referencing the practical experience of hospitals in the Huaxi Mucormycosis Collaboration Network in the diagnosis and treatment of mucormycosis. The aim is to provide reference and guidance for clinical decision-making.
